# Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

> **NCT01851863** · PHASE4 · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 262 (actual)

## Conditions studied

- Dyspepsia
- Compliance
- Depression

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Flupentixol-Melitracen(psychological and GI) + Omeprazole
- **DRUG:** Flupentixol-Melitracen(psychological) + Omeprazole
- **DRUG:** Flupentixol-Melitracen(without explanation) + Omeprazole

## Key facts

- **NCT ID:** NCT01851863
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2015-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851863, "Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01851863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*